• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[日本扩大流感疫苗接种策略的经济评估]

[An economic evaluation of strategy for expanding influenza vaccination in Japan].

作者信息

Hara Yuichi

机构信息

Department of Health Services Management and Policy, Kyushu University Graduate School of Medicine.

出版信息

Nihon Rinsho. 2003 Nov;61(11):2013-8.

PMID:14619447
Abstract

Two years ago, the Japanese government decided to partially pay the influenza vaccination cost for residents over 65 years. About 23 million people are over 65 years-old, and 8 million elderly were vaccinated in this program. Hospitals and clinics usually charge about 5,000 yen for each patient given a vaccination. Since this program pays about 80% of the charge, the government paid about 32 billion yen for this program. Few studies have been done of the economics of influenza in Japan. One study found the total cost of treating hospitalized patients and outpatients was about 489 billion yen. Another study found the hospitalization cost from influenza to be about 187,000 yen for each admission. Assuming the effect of vaccination to be 70%, hospitalization and outpatient costs would be reduced by about 45 billion yen. The hospitalization cost alone would be reduced approximately 25 billion yen. Influenza vaccination is obviously cost effective.

摘要

两年前,日本政府决定为65岁以上居民部分支付流感疫苗接种费用。65岁以上的人口约有2300万,其中800万老年人参与了该疫苗接种项目。医院和诊所通常向每位接种疫苗的患者收取约5000日元的费用。由于该项目支付约80%的费用,政府为此项目支付了约320亿日元。日本很少有关于流感经济学的研究。一项研究发现,治疗住院患者和门诊患者的总成本约为4890亿日元。另一项研究发现,每次因流感住院的费用约为18.7万日元。假设疫苗接种的效果为70%,住院和门诊费用将减少约450亿日元。仅住院费用就将减少约250亿日元。流感疫苗接种显然具有成本效益。

相似文献

1
[An economic evaluation of strategy for expanding influenza vaccination in Japan].[日本扩大流感疫苗接种策略的经济评估]
Nihon Rinsho. 2003 Nov;61(11):2013-8.
2
Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan.日本老年人流感和肺炎球菌疫苗接种的成本效益分析。
Kobe J Med Sci. 2006;52(3-4):97-109.
3
[Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland].[病毒性呼吸道感染和肺炎疾病对波兰老年人口的健康经济影响]
Pol Merkur Lekarski. 2010 Jul;29(169):37-40.
4
Cost of influenza hospitalization at a tertiary care children's hospital and its impact on the cost-benefit analysis of the recommendation for universal influenza immunization in children age 6 to 23 months.一家三级儿童专科医院的流感住院费用及其对6至23个月儿童普遍接种流感疫苗建议的成本效益分析的影响。
J Pediatr. 2005 Dec;147(6):807-11. doi: 10.1016/j.jpeds.2005.06.031.
5
Policy evaluation for the subsidy for influenza vaccination in elderly.
Vaccine. 2005 Mar 18;23(17-18):2256-60. doi: 10.1016/j.vaccine.2005.01.042.
6
[Cost-benefit analysis on the strategy of social health insurance regarding vaccination against influenza in Xi'an city].
Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Jan;29(1):17-22.
7
The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.澳大利亚针对50至64岁成年人的全民流感疫苗接种计划的成本效益。
Vaccine. 2008 Apr 16;26(17):2142-53. doi: 10.1016/j.vaccine.2008.01.050. Epub 2008 Feb 20.
8
Evaluation of a mass influenza vaccination campaign.大规模流感疫苗接种活动评估
Jpn J Infect Dis. 2001 Oct;54(5):184-8.
9
Could a federal program to promote influenza vaccination among elders be cost-effective?一项旨在促进老年人接种流感疫苗的联邦计划是否具有成本效益?
Prev Med. 2006 Mar;42(3):240-6. doi: 10.1016/j.ypmed.2005.12.004. Epub 2006 Feb 15.
10
Cost-effectiveness of influenza vaccination of healthy children.健康儿童接种流感疫苗的成本效益
Vaccine. 2006 Jun 5;24(23):4934-41. doi: 10.1016/j.vaccine.2006.03.057. Epub 2006 Apr 7.